Amedisys Inc (AMED)
Days of sales outstanding (DSO)
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Receivables turnover | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| DSO | days | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
December 31, 2024 calculation
DSO = 365 ÷ Receivables turnover
= 365 ÷ —
= —
Based on the provided data, Amedisys Inc's Days Sales Outstanding (DSO) figures are not available for the specific periods provided, as they are indicated as "— days" across all the dates from March 31, 2020, to December 31, 2024.
Without the actual DSO values for the mentioned periods, a detailed analysis of Amedisys Inc's DSO trends, efficiency in collecting accounts receivable, or comparison against industry benchmarks cannot be performed.
It is recommended to obtain the accurate DSO data points to conduct a meaningful analysis of Amedisys Inc's performance in managing its accounts receivable and cash flow. The DSO metric is crucial in assessing how quickly the company collects outstanding payments from its customers and plays a significant role in evaluating its liquidity position and overall financial health.
Peer comparison
Dec 31, 2024